These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9179515)

  • 1. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts.
    Miotto K; McCann MJ; Rawson RA; Frosch D; Ling W
    Drug Alcohol Depend; 1997 Apr; 45(1-2):131-4. PubMed ID: 9179515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Gossop M; Hegstad S; Kristensen Ø; Waal H
    Addiction; 2010 Sep; 105(9):1633-9. PubMed ID: 20707781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks associated with the inappropriate use of naltrexone in the treatment of opioid dependence.
    Latt NC
    Med J Aust; 1999 Nov; 171(9):500-1. PubMed ID: 10615348
    [No Abstract]   [Full Text] [Related]  

  • 5. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance of adverse events associated with naltrexone in New South Wales.
    Thackway SV; Ward PL; Taylor LK
    Med J Aust; 1999 Nov; 171(9):499-500. PubMed ID: 10615347
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.
    Hulse GK; Tait RJ; Comer SD; Sullivan MA; Jacobs IG; Arnold-Reed D
    Drug Alcohol Depend; 2005 Sep; 79(3):351-7. PubMed ID: 15899557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumstances of death of opioid users being treated with naltrexone.
    Darke S; Farrell M; Duflou J; Larance B; Lappin J
    Addiction; 2019 Nov; 114(11):2000-2007. PubMed ID: 31278812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-dependent error processing.
    Fellows-Smith J
    J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone in the treatment of opioid dependence.
    George S; Ekhtiari H
    Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073
    [No Abstract]   [Full Text] [Related]  

  • 11. Can psychotherapy rescue naltrexone treatment of opioid addiction?
    Rounsaville BJ
    NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
    [No Abstract]   [Full Text] [Related]  

  • 12. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
    Degenhardt L; Gibson A; Mattick RP; Hall W
    Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
    [No Abstract]   [Full Text] [Related]  

  • 13. Favorable mortality profile of naltrexone implants for opiate addiction.
    Reece AS
    J Addict Dis; 2010 Jan; 29(1):30-50. PubMed ID: 20390697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physical and psychosocial consequences of opioid addiction: an overview of changes in opioid treatment.
    Brown R; Lo R
    Aust N Z J Ment Health Nurs; 2000 Jun; 9(2):65-74. PubMed ID: 11271014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 16. Nalmefene hydrochloride.
    Chumpa A
    Pediatr Emerg Care; 1999 Apr; 15(2):141-3. PubMed ID: 10220088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of naltrexone in the treatment of young drug addicts].
    Waal H; Aamodt Ø; Olsen H
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1662-4. PubMed ID: 12821983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
    Gibson AE; Degenhardt LJ
    Drug Alcohol Rev; 2007 Jul; 26(4):405-10. PubMed ID: 17564876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and county-level variation in outcomes following non-fatal opioid-involved overdose.
    Lowder EM; Amlung J; Ray BR
    J Epidemiol Community Health; 2020 Apr; 74(4):369-376. PubMed ID: 31919146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.